ABIOLA OYEMADE: Open Payments
NPI 1417454992 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 11 payments from 4 companies in 2025. Trend: 2023 $768 · 2024 $486 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $210 |
| Otsuka America Pharmaceutical, Inc. | 4 | $157 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Janssen Pharmaceuticals, Inc | 2 | $88 |
Products named: LYBALVI, ABILIFY MAINTENA, INVEGA SUSTENNA, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across TX — which companies pay providers there.
